Mohite Popat, Puri Abhijeet, Dave Roshan, Budar Aarati, Munde Shubham, Ghosh Shruti Bagchi, Alqahtani Taha, Shmrany Humood Al, Kumer Ajoy, Dhara Bikram
AETs St. John Institute of Pharmacy and Research, Palghar, Maharashtra.
Department of Pharmaceutical Chemistry, Calcutta Institute of Pharmaceutical Technology and Allied Health Science, Uluberia, Howrah.
Int J Surg. 2024 Oct 1;110(10):6432-6455. doi: 10.1097/JS9.0000000000001892.
This review explores the application of induced pluripotent stem cells (iPSCs) in regenerative medicine. The therapeutic significance of iPSC-derived cell therapy within regenerative medicine, emphasizes their reprogramming process and crucial role in cellular differentiation while setting the purpose and scope for the comprehensive exploration of iPSC-derived cell therapy. The subsequent sections intricately examine iPSC-derived cell therapy, unraveling the diverse derivatives of iPSCs and striking a delicate balance between advantages and limitations in therapeutic applications. Mechanisms of action, revealing how iPSC-derived cells seamlessly integrate into tissues, induce regeneration, and contribute to disease modeling and drug screening advancements is discussed. The analysis extends to clinical trials, shedding light on outcomes, safety considerations, and ethical dimensions. Challenges and concerns, including the risk of tumorigenesis and scalability issues, are explored. The focus extends to disease-specific applications, showcasing iPSC-derived cell therapy as a promising avenue for various medical conditions, supported by illustrative case studies. Future directions and research needs are outlined, identifying areas for further exploration, safety considerations and potential enhancements that will shape the future landscape of iPSC-derived therapies. In conclusion, this review provides a significant understanding of iPSC-derived cell therapy's status that contemplates the implications for regenerative medicine and personalized treatment using iPSCs, offering a comprehensive perspective on the evolving field within the confines of a dynamic and promising scientific frontier.
本综述探讨了诱导多能干细胞(iPSC)在再生医学中的应用。iPSC衍生细胞疗法在再生医学中的治疗意义,强调了其重编程过程以及在细胞分化中的关键作用,同时设定了全面探索iPSC衍生细胞疗法的目的和范围。随后的章节深入研究了iPSC衍生细胞疗法,揭示了iPSC的各种衍生物,并在治疗应用的优势和局限性之间取得了微妙的平衡。讨论了作用机制,揭示了iPSC衍生细胞如何无缝融入组织、诱导再生以及对疾病建模和药物筛选进展的贡献。分析扩展到临床试验,阐明了试验结果、安全考虑因素和伦理层面。探讨了挑战和问题,包括肿瘤发生风险和可扩展性问题。重点扩展到特定疾病的应用,通过实例研究表明iPSC衍生细胞疗法是治疗各种医疗状况的一条有前途的途径。概述了未来的方向和研究需求,确定了进一步探索的领域、安全考虑因素以及将塑造iPSC衍生疗法未来格局的潜在改进。总之,本综述对iPSC衍生细胞疗法的现状有了重要的认识,考虑到其对再生医学和使用iPSC进行个性化治疗的影响,在一个充满活力和前景的科学前沿范围内提供了对这个不断发展领域的全面视角。